FDA inspection
Danny Rischin, MBBS, FRACP, MD: FDA inspection ending Aug 22, 2025
FDA inspection 1281734 · Voluntary Action Indicated (VAI) · Melbourne
Key facts
| Inspection ID | 1281734 |
|---|---|
| Firm | Danny Rischin, MBBS, FRACP, MD |
| FEI number | 3038201891 |
| Address | Peter Maccallum Cancer Centre, 305 Grattan Street |
| City | Melbourne |
| Country | Australia |
| Fiscal year | 2025 |
| Inspection end date | Aug 22, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data